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Abstract  
 
Background:  
Decades of effectiveness research has established the benefits of using patient decision aids (PtDAs), yet 
broad clinical implementation has not yet occurred. Evidence to date is mainly derived from highly 
controlled settings; if clinicians and healthcare organisations are expected to embed PtDAs as a means 
to support person-centred care, we need to better understand what this might look like outside of a 
research setting. 
 
Aim:  
This e ie  as o du ted i  espo se to the IPDA“ Colla o atio s e ide e update process, which 
informs their published standards for PtDA quality and effectiveness. The aim was to develop context-
specific program theories that explain why and how PtDAs are successfully implemented in routine 
healthcare settings.  
 
Methods:  
Rapid realist review methodology was used to identify articles that could contribute to theory 
development. We engaged key experts and stakeholders to identify key sources; this was supplemented 
by electronic database (Medline and CINAHL), grey literature, and forward/backward search strategies. 
Initial theories were refined to develop realist context-mechanism-outcome configurations, and these 
were mapped to the Consolidated Framework for Implementation Research.  
 
Results:  
We developed eight refined theories, using data from 23 implementation studies (29 articles), to 
describe the mechanisms by which PtDAs become successfully implemented into routine clinical 
settings. Recommended implementation strategies derived from the programme theory include: 1) co-
production of PtDA content and processes (or local adaptation); 2) training the entire team; 3) preparing 
and prompting patients to engage; 4) Senior level buy-in; 5) measuring to improve.  
 
Conclusions:  
We recommend key strategies that organisations and individuals intending to embed PtDAs routinely 
can use as a practical guide.  Further work is needed to understand the importance of context in the 
success of different implementation studies. 
 
 
 4 
1. Introduction 
Decades of effectiveness research has firmly established the patient-level benefits of using patient 
decision aids (PtDAs).(1,2) More work is needed to assess the true impact of routine PtDA 
implementation on healthcare users and providers, but the promising benefits and lack of harms 
identified by controlled studies has led to strong international policy support for more person-centred 
healthcare systems underpinned, in part, by increasing implementation of PtDAs.(3–9) However, broad 
clinical implementation has not yet occurred, and there is a notable intention-behaviour gap when 
PtDAs are used outside experimental studies in routine clinical settings.(10)  
PtDAs support patients  participation in shared decision making (SDM) with healthcare professionals, by 
making options explicit, providing evidence based information about the associated benefits / harms, 
and helping patients to consider what matters most to them in relation to the possible outcomes.(1) 
Formats vary (e.g. paper-based, DVD, website) and distribution methods can be tailored to the condition 
and setting, with PtDAs being delivered either as part of the clinical pathway (e.g. made available to 
patient before or during consultation) or via direct-to-consumer approaches (e.g. for population-level 
cancer screening programmes, access provided via screening invitations). Various studies have 
examined and described key factors that influence successful implementation of SDM more broadly. 
(11–15) Interventions studied include PtDAs and other approaches that encourage SDM behaviours, 
including patient activation materials and clinician SDM skills training.  
The International Patient Decision Aid Standards (IPDAS) Collaboration review published in 2013 (16) 
explored the success levels of different implementation strategies and included findings from controlled 
trial settings. Key barriers identified in the 2013 review included healthcare professionals  (HCPs) 
attitudes towards SDM, lack of understanding in how to use PtDAs and undertake SDM, HCPs lack of 
trust in PtDA content, lack of clarity among HCPs regarding the purpose of PtDAs in relation to other 
information available for patients, HCPs believing that patients do not want decisional responsibility, 
competing clinical demands, and the time it would take to distribute and use the PtDA. Key facilitators 
included system level approaches (e.g systematic identification of patients ahead of appointments via 
electronic health records and distribution methods that did not rely on HCPs to initiate access), SDM 
and/or PtDA training and skills development, and dedicated clinical leadership (e.g. clinical champion).  
 5 
Despite their benefits and various policies mandating their dissemination and use,(3–9) widespread 
adoption of PtDAs has not occurred, and significant gaps exist in understanding factors contributing to 
adoption, implementation, and sustainability of these interventions in routine clinical settings. Strong 
foundational research has examined the implementation of SDM in healthcare, typically through large-
scale demonstration projects (e.g. Informed Medical Decisions Foundation/Healthwise),(17,18) and 
excellent examples of local adoption also exist (e.g. Dartmouth Hitchcok Medical Center, USA).(19) The 
literature listing barriers and facilitators of PtDA dissemination and implementation, as perceived by 
HCPs and patients, is also well established.(16) However, despite the valuable learning, much of it is 
derived from highly controlled settings, which might not be representative of day-to-day processes and 
resources (human or financial) in routine clinical settings. Further, whilst lists of barriers and facilitators 
are useful markers to guide efforts to embed PtDAs, they provide less insight into why and how these 
factors influence implementation and can overlook the relations between different factors.(20) PtDAs 
a e ot agi  ullets  that ill al a s deli e  the i te ded e efits to patie ts; thei  useful ess will 
ultimately depend on context and implementation.(21) If clinical teams and organisations are being 
encouraged or mandated (e.g. clinical guidelines) by national health agencies to embed PtDA as a means 
to support person-centred care, we need to better understand what this might look like outside of a 
research setting, which contexts are likely to be more successful, and which  might face additional 
challenges.  
This current review was conducted in response to the IPDAS Collaboration s evidence update process, 
which informs their published standards for PtDA quality and effectiveness.(22–24) It updates the 
theory and evidence provided in the 2013 review (16,25) through the sole i lusio  of eal- o ld  data, 
exclusion of data from highly controlled settings, an understanding of the contexts that enable or hinder 
implementation, and the mechanisms (i.e. ha ges i  people s easo i gs a d a tio s) through which 
implementation is achieved. The main aim of this current review is to develop context-specific program 
theories that explain why and how PtDAs are successfully implemented in routine healthcare settings, 
providing a framework that will be useful to various stakeholders committed to embedding these tools 
routinely.  
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2. Method 
We used rapid realist review (RRR) methodology (26) and the RAMESES publication standards for realist 
reviews.(27) RRR methodology moves beyond traditional reviews by allowing researchers to answer 
questions about why interventions in complex social contexts, such as routine healthcare, work or do 
not work.(28) We chose this method as it allowed us to look beyond the overall success of a PtDA 
intervention to generate explanations about what works for whom, in what contexts, to what extent, 
and most importantly, how and why?(28)  
The resulting knowledge synthesis highlighted possible interventions (I) that could be implemented in a 
specific context (C) that in turn interact with various mechanisms (M) and produce outcomes (O) of 
interest;(28) in this case, implementation of PtDAs in routine healthcare settings (see Box 1 for 
definitions of specific terminology). Two reviewers (NJW and TvdW) conducted a scoping exercise of 
existing literature examining barriers and facilitators to implementing PtDAs and SDM (9,11–
13,16,25,29,30) to agree on the review questions and scope, and to generate initial theories. The a priori 
proposal was reviewed and approved by the IPDAS Steering Committee and registered with PROSPERO 
(CRD42019153334).  
We followed the key stages of a RRR: identifying scope/research questions, identifying literature for 
inclusion, quality appraisal, data extraction, and data synthesis.(26) Our specific foci were to engage key 
experts and stakeholders to streamline the review process, produce useful results for those planning to 
implement PtDAs, and to create a set of recommendations for the IPDAS Collaboration s updated 
evidence document for PtDA implementation. We convened a review team (named co-authors, led by 
NJW and TvdW) identified via the IPDA“ Colla o atio s all fo  e ide e update hapte  autho s to 
support the review process in the areas of literature identification, data extraction, and theory 
development. Typically, RRRs i ol e o sultatio  ith a oade  e pe t panel  to identify literature 
and corroborate theory development; however, as the review team consisted of a number of key 
international experts in the field of PtDA development, evaluation, and implementation, representing a 
range of disciplines and backgrounds, the review team also fulfilled this role.  
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Box 1: Glossary of key terms and abbreviations 
 
Identifying and selecting literature for inclusion   
The review team identified an initial list of potential articles that could contribute to theory 
development, and a list of known organisations and individuals involved in the implementation of PtDAs. 
The lead authors (NJW / TvdW) screened articles to determine if they could likely contribute to 
understanding what facilitates and/or hinders PtDA implementation in routine clinical settings. Articles 
were included if the study reported implementation of a PtDA (as defined by the IPDAS Collaboration)(1) 
in a routine healthcare setting (defined as daily situations without significant additional resources, 
where clinicians and/or providers had been encouraged to integrate the PtDA into usual care routines) 
and if PtDA and dissemination / implementation strategies were described. Articles were excluded if the 
study used an intervention not classified as a PtDA(1) (e.g. education resource, information leaflet), if 
the PtDA supported decisions about health insurance / provider options, or if the PtDA was 
implemented in highly controlled settings, such as randomised controlled trials or process evaluations 
o du ted as a si li g  stud  assessi g i ple e tation in a controlled research setting). Whilst 
secondary analysis of experimental studies has its relevance, we chose to exclude sibling studies 
associated with experimental studies that focus on measuring efficacy or effectiveness of PtDAs. These 
studies likely bypassed routine clinical procedures to enlarge the effect of the PtDA, thus being less 
representative of everyday clinical settings, and would have limited bearing on our programme theory. 
Studies exploring routine implementation of SDM outside controlled settings are relatively new, and our 
aim was to build on the 2013 review, and so articles were restricted to a 10-year period (2009 – 2019). 
Context (C) 
Pre-existing conditions outside the control of the intervention developers which influence the 
success or failure of the intervention (ref Pawson and Tiley 2008)  
Mechanism (M) 
Peoples  ea tio s  to the i ple e tatio  of the i te e tio ; ho  does it change their reasoning 
and actions? (ref Pawson and Tiley 2008) 
Outcome (O) 
Intended and unintended consequences of the intervention as a result of a mechanism operating 
within a context (ref Pawson and Tiley 2008) 
Intervention (I)  Features of the intervention resource (ref Pawson and Tiley 2008) 
Implementation 
The constellation of processes intended to get an intervention into use within an organisation (ref 
Rabin et al 2008) 
Patient Decision Aid 
(PtDA) 
Interventions that support patients to make decisions, by making decisions explicit, providing 
information about options and associated benefits / harms, and helping clarify congruence 
between decisions and personal values. (ref Stacey 2017) 
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There were no restrictions regarding PtDA format (e.g. web-based, paper-based), type of decision, 
healthcare settings, or population/participants.  
Using the initial set of articles, a combination of free-text and MeSH headi gs elated to de isio  aids , 
and sha ed de isio  aki g , a d i ple e tatio  e e used to de elop a Medline search strategy, 
which was adapted for use in CINAHL (see Supplementary File 1 for Medline search strategy). Relevant 
websites (e.g. databases of funders who support PtDA implementation programmes), policy documents, 
and known individuals and organisations were consulted to determine if any unpublished works relating 
to the review questions were available. Citations were exported to EndNote; titles and abstracts of all 
papers identified via electronic searches were screened (TvdW) to determine if they could answer the 
review question. Potentially relevant articles were obtained and full-texts were screened (NJW and 
TvdW) against our inclusion/exclusion criteria (noted above). Reference lists of included studies were 
consulted for forward and backward searching, and a clear audit trail of all data sources was maintained.  
Data extraction  
A data extraction team was convened from members of the broader review team, and a data extraction 
template was developed, piloted and streamlined to increase emphasis on context-mechanism-outcome 
(CMO) configurations. In the final version, qualitative, quantitative, and contextual data that could 
answer our review questions were extracted under the following broad categories: study / participant 
characteristics; PtDA characteristics; dissemination & implementation; implementation evaluation data 
(e.g. reach, dose, feasibility); data supporting emerging theories about what works, how, and in what 
circumstances, for implementation of PtDAs (If-Then Statements). NJW coordinated extractions 
completed by the data extraction team members, checked accuracy and consistency of data extracted, 
and consulted with individuals when necessary to clarify information or resolve discrepancies. 
Data synthesis  
Explanatory data in the results sections of included studies elati g to hat works in implementing 
PtDAs?  e e i itiall  e t a ted as If-The  state e ts that described links between elements of 
contexts, mechanisms, and outcomes. As the synthesis progressed, comparable If-Then statements were 
grouped by NJW, whilst ensuring linkage to the original data and source of the individual If-Then  
statements. We applied Pa so s reasoning processes(31) to generate refined CMO configurations 
 9 
based on the grouped If-The  “tate e ts see “upple e ta  File  fo  e a ple p o ess of theory 
development). Realist reviewers typically make use of existing theories to make sense of the evidence 
generated during their review. We chose the Consolidated Framework for Implementation Research 
(CFIR)(32) to help us interpret the findings emerging from the data, as it is designed to guide systematic 
assessment of multilevel implementation contexts to identify factors that might influence intervention 
implementation and effectiveness. It is composed of five major domains, each made up of several 
constructs (see Box 2 for domain descriptions). The initial draft of CMOs was presented back to the 
review team, who were asked to assess validity, relevance to the research questions, and importance of 
the inferences made. Feedback from the review team was used to refine the program theory (three 
iterations), to exclude theories viewed as less important and relevant, and to inform further data 
searches for elements that were perceived as missing, based on prior knowledge and experience.  
Box 2: Definitions of the five major domains of the Consolidated Framework for Implementation Research (32)  
I – Intervention Characteristics 
Features of an intervention that might influence implementation. Eight constructs: intervention source, evidence 
strength/quality, relative advantage, adaptability, triability, complexity, design quality, cost.    
II – Outer Setting 
Features of the external context that might influence implementation (economic, political and social context 
within which organisation resides). Four constructs: patient needs and resources, cosmopolitanism, peer pressure, 
external policies and incentives.  
III – Inner Setting 
Features of the implementing organisation that might influence implementation (e.g. structural, political, cultural 
contexts through which implementation will proceed). Twelve constructs: structural, networks/communications, 
culture, tension for change, compatibility, relative priority, organisational incentives and rewards, goals and 
feedback, learning climate, leadership engagement, available resources, access to information/ knowledge.    
IV – Characteristics of Individuals 
Characteristics of individuals involved in implementation that might influence implementation. Five constructs: 
knowledge and beliefs about intervention, self-efficacy, individual stage of change, individual identification with 
organisation.   
 V – Process  
Strategies or tactics that might influence implementation. Four constructs: planning, engaging, executing, 
reflecting and evaluating.  
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3. Results 
A total of 29 articles from 23 distinct studies contributed data to the developing theories. Figure 1 
outlines the review process, including data sources and exclusions, and Table 1 presents the key 
characteristics of included studies. Most studies were from the USA (n=14/23) and used a mixed-
methods approach (n=19/23). Seven studies specifically state that they were underpinned by quality 
improvement methodology. PtDA delivery varied between the studies, including distribution to patients 
before the decision-making consultation (n=11); use during the decision-making consultation (n=6); or 
distribution to providers (n=6). A variety of PtDA formats were used (e.g. video, web-based, paper-
based) across a range of health and behavioural contexts (e.g. cancer, mental health, maternity, family 
planning, orthopaedics) for a range of treatment or management decisions (see Supplementary File 3 for 
details) in various different settings (e.g. community-based, primary care, secondary / specialist care). 
Implementation strategies differed across the studies, ranging from motivated clinicians embedding 
PtDAs into their clinics with limited additional support and resources, to structured implementation 
programmes using quality improvement methodology with direct and continuous support from 
implementation teams with expertise in these methods. Full details of study type, setting, PtDA 
characteristics and implementation strategy can be found in Table 1. The review team consisted of 18 
international SDM experts representing nine countries (USA (n=5), Canada (n=4), United Kingdom (n=3), 
Australia (n=1), Chile (n=1), Denmark (n=1), France (n=1), Germany (n=1), The Netherlands (n=1)). The 
team represent a range of professional backgrounds: health services research (n=7); medical (n=4); 
psychology (n=2); nursing (n=2); epidemiology (n=1); public health (n=1); allied health professions (n=1). 
Data extraction was conducted by 15 members of the review team, and two additional researchers 
linked with review team members. All members contributed to theory development and refinement.  
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Figure 1: Data searches and sources of included articles 
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Table 1: Characteristics of included studies (n = 23 from 29 articles), grouped according to method of PtDA distribution  
Author, Year, 
Country, 
Linked studies 
Study Aim(s), Study Type, Setting  PtDA Characteristics, intended distribution and use Implementation strategy & duration   Process outcome data  Supports 
theory 
number 
PtDAs first distributed to patients before decision making consultation 
Belkora,   
2012, 
USA(33) 
 
 
To examine the reach and impact of five 
PtDAs routinely distributed to breast cancer 
patients as part of a SDM demonstration 
project.  
Case series (quantitative). 
Large multi-disciplinary breast cancer 
centre.  
Five video-based breast cancer PtDAs covering 
different decision points (ductal carcinoma in situ; 
early-stage surgery; breast reconstruction; adjuvant 
therapy; metastatic cancer). Decision Services 
personnel calls patient prior to appointment offering 
decision support materials/services, including 
appropriate PtDA. If required, PtDA mailed to patient 
within 24hrs. Accompanied by before and after 
knowledge survey. 
 
Decision Services already integrated into the Breast Cancer 
Centre and oversaw routine distribution of the suite of 
PtDAs as part of routine care, while measuring process and 
outcome data.  
36 months implementation phase.  
61% (1098/1800) of new 
breast cancer patients 
received PtDA at home 
address, after call for 
consent. Reach attained 
70% in the final year of 
implementation.  
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Berry, 
2019, 
USA(34) 
To assess various implementation strategies 
for the Personal Patient Profile-Prostate 
decision aid (P3P), by measuring referral 
and access rates to P3P, and analysing 
feedback from clinical staff and providers. 
Hybrid Type 1 effectiveness-implementation 
trial (mixed-methods).  
Secondary care (urology and 
multidisciplinary clinics in large hospitals).  
Personalised web-based PtDA for localised prostate 
cancer. Distribution methods varied depending on 
clinic (e.g. independent tool or integrated into existing 
educational resources), but all involved distributing link 
to the PtDA after disclosure of positive biopsy, but 
before full options review visit. Patient has option to 
print and take PtDA report to decision making 
consultation, or email to clinic to be used during the 
consultation. iPads provided at each site before 
consultation for those men without internet access.  
Conducted as part of hybrid type 1 effectiveness-
implementation trial. Six largest volume urology and 
multidisciplinary clinics participated in prior randomised 
effectiveness study selected. Planning session convened at 
each site to develop workflow for implementation. 
Physician staff received presentation about study 
aims/publications; face-to-face nurse/staff meetings 
reflected on current practice, considered various 
approaches that would fit best; web trainings conducted 
with clinic staff (including coordinators and nurses); staff 
provided with instruction sheets and flyers for PtDA 
referrals.  
Approx. 6-month implementation phase  
51% (252/495) of patients 
were informed about 
PtDA. 43% (107/252) 
accessed the PtDA.  
Invitation via personal e-
mail / telephone contact 
resulted in 82-87% PtDA 
access rates. Written 
invitations only resulted in 
0% to 14% access rates.  
3a, 3b, 
3c, 4a, 
5a, 7 
Brackett,  
2015, 
USA(35) 
To facilitate SDM during preventative visits 
by utilising a web-based survey system to 
offer colorectal cancer and prostate cancer 
screening decision aids to appropriately 
identified patients prior to the visit.  
Observational (quantitative). 
Academic general medical practice.  
PtDA (content not the same, different developers). 
Eligibility to receive PtDA determined prior to 
appointment. Patients offered choice of video or print 
version. If accepted, mailed to patient before 
appointment. Also completed knowledge and personal 
value questions. Knowledge provided in written report 
for patient; this report and a preference report fed 
forward to clinician available at decision-making 
consultation.    
One academic general medical practice. Limited 
information provided about implementation strategy.   
38 months implementation phase (Jan 2008 – March 2011).  
15% (552/3587) of 
patients that had not 
previously received a PtDA 
requested the PtDA after 
digital invitation. Patients 
could choose between 
video or written PtDA. 74% 
choose the written format. 
The most common reason 
to decline PtDA was the 
patie t s elief that they 
already knew enough to 
make the decision.  
1, 7 
Dharod,   
2019, 
USA(36) 
Determine the feasibility of a digital health 
strategy for lung cancer screening delivered 
via a patient portal  
Single arm pragmatic trial  
 
Interactive website with personalised risk-benefit 
information (mPATH-Lung). Electronic health record 
algorithm developed to identify eligible patients. 
Invitation to view PtDA sent via patient portal. After 
ie i g PtDA, patie ts ho ote es  o  a e  to 
the uestio   ould ou like to e ei e s ee i g  
Conducted as part of a single-arm pragmatic trial in large 
academic health system, including 4 hospitals and 70 
community-based clinics. Informed consent waived by 
review board as embedded as part of routine care. Limited 
information about implementation strategy.  
40% (400/1000) of current 
or former smokers visited 
the web based PtDA after 
digital message sent via 
patient portal. Median 
number of days between 
5a, 7 
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Author, Year, 
Country, 
Linked studies 
Study Aim(s), Study Type, Setting  PtDA Characteristics, intended distribution and use Implementation strategy & duration   Process outcome data  Supports 
theory 
number 
Large academic health care system (4 
hospitals and 70+ community-based clinics)  
scheduled follow-up in-person SDM visit with nurse 
practitioner.  
4 months implementation phase (Nov 2016-Feb 2017).  reading the message and 
PtDA = 0.4 (range 0-75). 
Dontje,  
2013,  
USA(37) 
 
Holmes-Rovner, 
2011(38) 
 
To develop and evaluate feasibility of a 
multifaceted SDM interventions to prompt 
SDM in primary care about angiography in 
stable coronary artery disease.  
 
Pilot cohort study (quantitative and 
qualitative) 
 
Academic clinics (family and internal 
medicine)  
Paper- ased a d DVD PtDA Treatment choices for 
Coronary Artery Disease . Eligible patients mailed 
PtDA and asked to review before they attended a 90 
min group educational visit (where they then 
completed a one-page treatment encounter planning 
guide). Patient instructed to take the PtDA and 
completed treatment encounter planning guide to 
their appointment (SDM discussion).  
Two academic clinics. Unclear why clinics were selected. 
Provider training included (1) clinical content in Grand 
Rounds, (2) provider training in communication skills and 
clinical evidence review in the form of a ninety-minute 
workshop that could be delivered as continuing medical or 
nursing education or as a noon time conference.  
Recruitment three months. Implementation phase not 
reported.  
17% (43/247) patients 
invited to review a PtDA. 
PtDA sent following signed 
consent. Actual use of the 
PtDA is not reported. Self-
selection of participants, 
who were the more 
engaged and motivated in 
their care, seems to have 
occurred. 
1 
Krist,  
2017,  
USA(39) 
To examine whether patients and clinicians 
will use a novel health information 
technology (decision module) and its impact 
on care across three cancer screening 
decisions.  
Observational cohort study (quantitative). 
12 primary care practices (breast, colorectal 
and prostate cancer).  
Three online PtDAs, informed decision-making (IDM) 
modules for the following decisions: when to start 
breast cancer screening, how to be screened for 
colorectal cancer, and not being screened for prostate 
cancer. Guides patients through 7 steps 1) sent to 
patient via patient portal prior to consultation; 2) 
assesses personal preferences, knowledge, and needs 
a d patie ts  eadi ess to ake a de isio ;  p o ides 
personalised education material tailored to 
preferences and decision stage; 4) allows patients to 
share their preferences and decision needs with their 
clinician; 5) provides prompt to patient and HCP to use 
the information to make a decision; 6) guides patients 
to make a choice, which can include deferring the 
decision; and 7) invites patients and clinicians to 
provide input after the encounter.  
 
12 primary care practices who used electronic health 
records. PtDA delivery integrated into central patient portal 
(MyPreventiveCare). No further information provided 
regarding selection of primary care practices.  
 
Eight months implementation phase (January – August 
2015).  
At time of study, 55,453 
patients (34.5% of practice 
population) had a portal 
account. 23,546 used 
portal during study period 
(some evidence that users 
were more likely to be 
older or have 
comorbidities and were 
less likely to be Hispanic or 
African American).  
 
NJW TO ADD FURTHER 
PROCESS DATA 
5a, 7 
Lin,  
2013, 
USA(40) 
To explore processes for distributing PtDAs 
to patients in clinical settings and to identify 
barriers and facilitators to implementation. 
Qualitative and quantitative data sources 
(collected as part of a prior implementation 
project). 
Primary care practices.  
Clinics could choose from choice of 16 PtDAs (could 
choose multiple topics). 14/16 were booklet and DVD, 
2/16 were booklet only. PtDA delivery adapted by each 
clinic depending on needs/clinic workflow (i.e. 
distributed by physician/medical assistants in person, 
solicitation of patient interest at point of care; direct 
mailing). Designed for use inside and outside the 
consultation.  
Physician and staff champion established in 5 primary care 
clinics. Physician champion provided information about 
p oje t to ea h li i s leadership team. Both champions 
responsible for promoting the programme. Project team 
members collaborated with clinics to agree on PtDA topics 
tailor decision aid distribution methods to clinic workflow. 
Project team attended bimonthly meetings with project  
team and engaged in social marketing efforts.  
Jan 2010 – June 2012 (29 months implementation phase)  
Overall rate of distribution 
of PtDA was 10%. The 
longitudinal data show a 
decrease in distribution of 
PtDA instead of a 
sustainable increase. 
3a, 3b, 
3c, 4a, 
4b, 6, 7,  
Savelberg, 
2019a, 
The 
Netherlands(41) 
 
Savelberg 
2019b(42) 
To explore experiences (including perceived 
barriers & facilitators), issues, and concerns 
of early-adopter professionals with regard 
to SDM, and the specific lessons on 
implementation of a breast cancer PtDA 
within an oncological clinical pathway.  
Personalised web-based PtDA for early-stage breast 
cancer decisions (curative surgery, chemotherapy, 
reconstructive surgery). Patient receives personalised 
written prescription from clinician during diagnostic 
consultation (with relevant decision points and log-in 
code); patient views PtDA at home before decision-
making consultation.  
Seven breast cancer teams (consisting of at least one 
surgeon and one nurse) with positive attitudes towards 
SDM and willingness to improve SDM process were 
recruited. Meeting arranged with each team (all team 
members) prior to implementation with focus on tailoring 
implementation, covering: 1) recommendations on how to 
present PtDA to patient; 2) minor adjustments to pathway; 
91% (77/85) of patients 
received access to the 
PtDA at first consultation. 
73% (56/77) of patients 
logged on to web based 
PtDA. PtDA delivery 
started in tumour board: 
3b, 4a, 
4b, 5b, 6, 
8 
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Observational prospective process 
evaluation (mixed-methods)  
Secondary care (hospital setting)   
 3) watching 10min lecture and 5min motivational video on 
SDM (skills/role modelling).  
24 months implementation phase (June 2015-June 2017).  
Tumour board letter 
reported 2 treatment 
options 58% (50/85), and 
indication for PtDA 34% 
(29/85). 
Sepucha, 
2017, 
USA(43) 
Mangla 
2018(44)  
Sepucha 2017 – evaluate the impact of a 
quality improvement project to increase use 
of orthopaedic PtDAs and examine whether 
PtDAs increase SDM in routine care.  
Quality improvement methodology.  
Tertiary referral centre  
Mangla 2018 – to use quality improvement 
methodology to test methods of PtDA 
delivery to increase use of four orthopaedic 
PtDAs (as listed above).  
Quality improvement methodology. 
Secondary care (large orthopaedic hospital 
department) and 18 primary care practices. 
  
Four PtDAs for orthopaedic treatment / management 
options: 1) Treatment Choices for Knee Osteoarthritis 
(42 min DVD; 38-page booklet); 2) Treatment Choices 
for Hip Osteoarthritis (44 min DVD; 40 page booklet); 
Treatment Choices for Herniated Disk (44 min DVD; 40 
page booklet); 4) Treatment Choices for Spinal Stenosis 
(44 min DVD; 40 page booklet). Sent to patient ahead 
of the consultation if feasible. Process of determining 
eligibility for PtDA and subsequent distribution process 
differed depending on condition (e.g. automated via 
electronic medical system and sent before consultation 
or by specialist and handed to patient during 
consultation).  
 
 
 
Single academic hospital serving a tertiary referral centre. 
Clinicians and staff at this site were already aware of and 
able to order PtDAs via the electronic medical record, 
which were delivered after the consultation. This quality 
improvement programme aimed to increase usage of the 
PtDA by working with primary care clinicians, specialist and 
clinic staff to design a more reliable process to identify 
eligible patients and to send them the PtDA in advance of 
the visit (e.g. at the time of referral from a primary care 
physician or at the time of scheduling a visit for new 
patients. When a PtDA is ordered, it automatically placed a 
note in the medical record documenting that it was sent. 
Process could be adapted if needed (e.g. process for 
arthroplasty and spine services differed). One-time bonus 
for targets reached (viewing/ordering PtDA). Integrated 
into quality improvement programmes with dedicated lead 
and clinical champions.  
Eighteen month implementation phase (2013-2014) 
65% (303/469) of patients 
were identified by 
surgeons as eligible to be 
sent home with PtDA, 
indicated by automatic not 
in patient record. 62% 
(188/303) of these 
patients reported reading 
the entire PtDA. 
6, 7  
Stacey, 
2015, 
Canada(45) 
Evaluate a sustainable approach for 
implementing a PtDA for adults with cystic 
fibrosis (CF) considering referral for lung 
transplantation.  
Prospective pragmatic observational study.  
Eighteen adult CF clinics within eight 
different provincial healthcare systems in 
Canada.  
 
Printed copies and web-based version of the PtDA. 
Sent to patients ahead of consultation to discuss 
possible referral. Patient asked to complete PtDA on 
their own, which produces one-page summary report. 
This is shared and discussed with the clinician during 
the appoi t e t, a d also filed i  the patie t s edi al 
records.  
Healthcare professionals involved in the care of adults with 
CF invited to participate in implementation study. Of 
twenty-three CF clinics, 18 participated. Various 
implementation interventions including: a) a five hour 
knowledge / skills workshop (participants received 
monetary honorarium); b) Ottawa Decision Support 
Tutorial (online) offered to those who could not attend 
workshop; c) access to the PtDA (paper and online; d) 
conference calls 3 monthly in first year, then twice a year 
(reinforce learning and provide support). Guided by the 
K o ledge to A tio  f a e o k.  
 
Project duration 24 months.  
Across 15 clinics, 18 of 62 
CF patients used PtDA 
(29%) at baseline. After 
initiating implementation 
interventions, 15 clinics 
reported that PtDA was 
used by 58 of 68 patients 
(85%) in year one and 54 
of 59 (92%) in year 2,  
 
  
7 
Stacey,  
2018, 
Canada(46) 
Compare two strategies for implementing 
PtDAs in clinical pathways for men with 
localised prostate cancer.  
Comparative case study (mixed methods)   
Secondary care, two academic teaching 
hospitals. 
Case 1: Video and booklet version of PtDA containing 
information about prostate cancer treatment 
(including benefits and harms), values clarification 
exercise, and video patient testimonials. Also given 
decision quality and SURE questionnaire. Handed to 
patient during initial appointment (biopsy result); 
urologist met patient and instructed nurse to provide 
the PtDA to the patient for the next in-person 
appointment; clinician also received results of decision 
quality and SURE questionnaire (also put on file). Nurse 
Guided  the K o ledge to A tio  F a e ork.  
Nurses offered 3.5-hour workshop using Interprofessional 
Shared Decision making Model. Open to all healthcare 
professionals but only nurses, social workers and policy 
makers attended.  
 
 
Case one: 24 months (Jan 2011 – Dec 2012) 
Case two: 24 months (Jan 2014 – Dec 2015) 
Case 1 – 158 / 688 men 
(23%) received the PtDA. 
Consistent pattern of PtDA 
use over 2 years period.  
 
Case 2A – 265 / 270 men 
(98%) received PtDA. 
Consistent pattern of use 
over two years, but decline 
in volume used over time.  
7 
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(some trained in decision coaching) available by phone 
and next appointment.  
 
Case 2A: PtDA similar to version used in Case one, but 
adapted into a PowerPoint presentation and sent via 
email (did not include video patient testimonials). 
Patient called by nurse with biopsy result, and then 
sent PtDA via email (or mailed version used in Case 
One if they did not have email access). Asked to review 
ahead of in-person appointment. Trained nurse 
reviewed PtDA with patient and answered any 
questions; appointment then scheduled with urologist 
if patie t s p efe e es as to dis uss optio s.  
 
 
 
 
 
 
 
 
 
 
PtDA first used during decision-making consultation 
Bonfils,  
2018, 
USA(47) 
To explore the implementation process of a 
SDM intervention, CommonGround, which 
utilizes peer specialists and a computerized 
decision support center to promote SDM. 
Mixed-methods. 
Four treatment teams in a large Community 
Mental Health Center.  
Computer-based programme for people with mental 
illness housed in Decision Support Center: access 
fa ilitated  pee  spe ialists  oa hi g . Co pleted 
prior to decision-making consultation with psychiatric 
p o ide . P o ide  a  ie  health epo t  that is 
produced and can updated with agreed treatment 
plan.  
Four teams chosen due to previous successful 
implementation programme with different intervention. 
Target programmes agreed with the teams.  Visits to 
established implementation sites arranged. 
Implementation Coach (fully trained in CommonGround) 
assigned to team, monthly conference calls during early 
implementation. All staff trained, and new sessions 
provided for new staff/refreshers. Implementation 
overseen by leadership team, including three fidelity visits. 
22 months implementation phase (May 2013 – March 
2015).    
64% (107/167) of clients 
used the PtDA at least 
once by filling in pre-
consultation appointment 
goals. Completion was 
74% for ACT team clients 
and 56% for outpatient 
clients. After 2 years the 
center ceased using the 
PtDA. 
1, 2, 3c, 
4a, 7 
Brinkman, 
2017, 
USA(48)  
Develop and reliably implement a decision 
aid to facilitate SDM between clinicians, 
patients with juvenile idiopathic arthritis, 
and their families around medication 
choices for treatment of inflammatory 
arthritis. 
Quality improvement methodology.  
Primary care sites (rheumatology). 
Paper-based medication choice cards for juvenile 
idiopathic arthritis. Distributed to patient (and family 
member) during medication change discussion 
consultations.  
Overseen by project improvement team (quality 
improvement consultant, clinician researchers). Train the 
trainer workshop was held to train key clinician champions 
on the use of the medication decision cards so that they 
could train other clinicians at their sites on correct use. A 
supporting video was also developed and shared with the 
sites. Each site developed process maps to identify how the 
DA would fit their process. Teams also did iterative plan-do 
study-act cycles to identify implementation processes. 
 
Six-month implementation phase (March – August 2014).  
In 35% of visits where drug 
use was discussed, the 
PtDA (medication choice 
cards) was used. The PtDA 
was used as intended 
(parent was asked to pick 
the first card to discuss) in 
68% of visits where the 
PtDA cards were used. 
4b 
Dahl 
Steffensen, 
2018, 
Denmark(14)  
To report key lessons on the set-up of a 
Center for Shared Decision-Making at The 
Patie t s Ca e  Hospital in Vejle (Denmark)  
Case study report.  
Specialised cancer centre in large public 
hospital.  
Generic PtDA developed by clinicians and School of 
Design. The PtDA template was developed to adhere to 
the certification and quality criteria set by IPDAS. 
Various paper-based versions tested for the following 
settings (using generic PtDA framework): adjuvant 
breast cancer, diagnostic setting of suspicion of lung 
cancer, genetic testing, ovarian cancer, colorectal 
cancer and herniated disc. Generic preparation sheet 
Two-day training program in SDM offered to all clinicians by 
department leaders. Supported by strong leadership, 
commitment from hospital CEO and CMO. PtDA platform 
offered in web-based system; health care providers log in 
and use platform to build and develop PtDAs tailored to 
their specific needs, based on the adjustable template 
uild ou  o  PtDA   
 
No data on actual use. 
 
The Center has moved into 
next phase and started a 
systematic SDM 
implementation program 
across all hospitals in the 
region of Southern 
3a, 3c, 
4a, 5a, 
5b, 6,  
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viewed by patients before the clinical encounter and 
PtDA introduced during encounter.  
 
  
 
Duration of first implementation phase: 3 years 
 
Denmark (2019) 
Johnson, 
2010, 
Indonesia/ 
Mexico/ 
Nicaragua(49) 
To describe development and testing of a 
family planning counselling tool, and to 
discuss challenges and requisites for shifting 
to SDM from the extremes of decision-
making dominated by the provider, on one 
hand, or unaided by the provider, on the 
other hand. 
Mixed-methods (pre and post design)  
Various contexts within healthcare settings 
where family planning is discussed (e.g. 
maternity hospitals, primary /public health 
clinics).  
Dual purpose PtDA (patient-fa i g  a d jo  aid  
(clinician-facing). Double sided flip chart presenting 
contraception options, used during a counselling 
session between client and provider. Adapted to local 
language.  
 
 
 
Implemented in three family planning teams – Indonesia, 
Mexico, Nicaragua. 2-4 day training workshop delivered to 
providers ahead of implementation in routine care.  
Implementation phase 4 months Nicaragua, 1 month in 
both Mexico and Indonesia.  
No clear data reported on 
actual use of the 2-sided 
flip ha t  PtDA. 5  
videotaped consultations 
showed total consultation 
time 550 seconds. Mean 
number of seconds of eye-
contact on PtDA: patient = 
187, provider = 170. 
5b, 6 
Joseph-
Williams, 
2017, 
UK(13) 
 
Lloyd 2013;(50)  
THF 2013 
To understand what works and what does 
not work in implementing SDM in routine 
NHS settings.  
Quality improvement methodology (mixed-
methods). 
Eight primary care practices and seven 
secondary care hospital teams (head and 
neck cancer; paediatric ENT; renal; 
maternity; urology; and two breast cancer 
teams). Across two large University local 
health boards / trusts in the UK.  
Various paper-based brief PtDAs (1-4 pages) across 
arrange of conditions, distributed to and used with 
patients during consultations. Patient given PtDA to 
use after consultation (when decision was not being 
made in the same consultation).  
Implementation overseen by University-based team. Four 
dedicated facilitators supported teams to develop their 
own interventions/ measures/ implementation strategies, 
and conduct PDSA cycles. Key organisational leaders (e.g. 
medical director), clinical champions and patients part of 
leadership team.  
18 months implementation programme (August 2010 – 
February 2012). All teams designed tools/interventions to 
use with PtDA as part of programme and actual 
implementation phases varied across the teams. All teams 
attended SDM training as part of programme.  
No data on actual use. 
 
1, 2, 3a, 
3b, 3c, 
4a, 4b, 
5a, 5b, 6, 
7, 8 
Munro, 
2019, 
USA(51)  
To explore the feasibility and acceptability 
of two interventions for facilitating SDM 
about contraceptive methods with a 
particular focus on factors that influenced 
their implementation by clinical and 
administrative staff.  
Qualitative study (embedded within a 2X2 
factorial cluster randomised controlled 
trial).  
12 clinics where contraceptive counselling 
takes place.  
 
Two types of intervention designed to support female 
contraceptive options: 
Patient-targeted: a ti atio  ate ials deli e ed i  the 
clinic, prior to appointment (video on tablet computer 
and paper-based card reinforcing questions to ask 
during consultation). 
Provider-targeted: set of 7 one-page paper-based 
PtDAs on contraceptive methods (tear pads). Used by 
HCP during patient visit. And short SDM/PtDA training 
video and written guidance. 
Not all groups received PtDAs.  
12 intervention arm clinics (patient-targeted; provider-
targeted; both) out of total 16 total clinics in trial. Each 
clinic identified senior staff member to liaise with research 
team and facilitate implementation. Research team 
provided group orientation on trial. Following 
randomisation, an orientation on intervention was 
provided, during which the teams worked collaboratively to 
develop their own implementation strategy, considering 
patient workflow and routinely used patient/counselling 
materials. Short SDM/PtDA training video and written 
guidance on how to use PtDAs provided prior to 
implementation in 8/12 intervention arms.  
Duration not reported. 
No data on actual use. 3a, 3b, 
4a, 4b, 
5a, 5b, 6, 
8 
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PtDA distributed to providers 
Feibelmann, 
2011, 
USA(52) 
To trial a structured approach to 
disseminating breast cancer PtDAs to 
community breast cancer sites, and to 
explore the factors associated with 
successful, sustained implementation of 
PtDAs by the providers at these sites.  
Longitudinal study data examined, and 
cross-sectional mail/telephone survey.  
Cancer centres, hospitals, private practices, 
and patient resource centres.  
Videos/DVDs and accompanying booklet for five 
different breast cancer decisions (ductal carcinoma in 
situ; early-stage surgery; breast reconstruction; 
adjuvant therapy; metastatic cancer). Designed to be 
handed out be provider during consultation, for patient 
to watch/read following consultation. Limited further 
information on distribution / intended use.  
Sites contacted to ascertain interest; 93/195 signed 
agreements to distribute, 57/93 distributed PtDA to at least 
one patient. Sites identified one contact person. Limited 
further information regarding implementation planning, 
adaption into clinic workflows etc.  
Duration not reported. 
  
61% (57/93) of USA 
hospitals / practices that 
signed agreements to 
adopt PtDAs reported 
distribution of PtDA to at 
least one patient. 49% 
(46/93) reported to still 
use the PtDA one year 
later. 
3b, 3c, 
4a, 4b, 
5a, 8 
Giguere,   
2014, 
Canada(53) 
To measure the value and intention to use 
decision boxes (Dboxes) in practice and to 
describe barriers and facilitators of their 
use. 
Observational Quality improvement study 
(mixed methods with sequential 
explanatory design). 
Six Primary care practices.  
Eight different Dboxes (written in French and English) 
covering the following healthcare decisions: 1) 
Cholinesterase inhibitors to reduce the symptoms of 
Alzheime s disease ChEIs ;  A et lsali li  a id fo  
primary prevention of cardiovascular disease (ASA); 3) 
Faecal occult blood test to screen for colorectal cancer 
(FOBT); 4) Serum integrated test to screen women for 
fetal trisomy 21 (Prenatal); 5) Statins for primary 
prevention of cardiovascular disease (Statins); 6) 
BRCA1/2 gene mutation test to evaluate the risks of 
breast and ovarian cancer (BRCA); 7) Bisphosphonates 
to prevent osteoporotic fractures in postmenopausal 
women (Osteo); 8) Prostate-specific antigen test to 
screen men for prostate cancer (PSA). Delivered to 
clinician via email before consultation to help clinician 
recognise equipoise and the need to share decision 
with patient, and to support provision of information 
about risks and benefits of options.  
 
Eight different Dboxes were distributed to clinicians (one 
each week for 8 weeks of implementation study). Limited 
information regarding agreed implementation.  
 
 
No data on actual use. 
PtDA (Dboxes on tests or 
drugs) were intended to 
be reviewed by clinicians 
before consultation. 40% 
(190/472) of clinicians 
reported intention to use 
the PtDA. 
3c, 4b, 
5b, 7 
Hsu, 
2013, 
USA(54) 
 
Hsu 2016(55) 
Hsu 2013 - To identify factors that promote 
and impede integrating PtDAs into clinical 
practice in a large health care delivery 
system.  
Qualitative case study methodology. 
Speciality care – orthopaedics, cardiology, 
u olog , o e s health, general surgery, 
neurosurgery. 
Hsu 2016 – build on Hsu 2013 to understand 
how differences in provider attitudes across 
specialities may impact PtDA 
implementation and how provider attitudes 
DVD and booklet format. Patient could also view PtDA 
via patient portal. 
Hsu 2013: 12 PtDAs (35-55 mins) for several elective 
surgery procedures: orthopaedics (hip osteoarthritis, 
knee osteoarthritis), cardiology (coronary heart 
disease), urology (benign prostatic hyperplasia, 
prostate cancer), wo e s health ute i e fi oids, 
uterine bleeding), general surgery (early stage breast 
cancer, breast reconstruction, ductal carcinoma in 
situ), and neurosurgery (spinal stenosis, herniated 
disk).  
Hsu 2016: three PtDAs for the following elective 
surgical procedures: orthopaedics (hip osteoarthritis, 
System- ide i ple e tatio  a oss G oup Health s 
Western Washington Group Practice Division (serving 
366,000 members) across six speciality service lines. 
Implementation evaluation conducted by Group Health 
Research Institute, non-proprietary, public interest arm of 
Group Health.  
PtDAs provided to free of charge for first two years of 
demonstration project. 
24-month implementation phase. 
In the 24-month 
implementation period, 
9827 PtDAs were 
distributed to patients, via 
US mail, free of charge. 
The PtDAs could be 
ordered via electronic 
health record or patient 
portal. 
2, 6 
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shift after PtDA implementation. 
Qualitative case study methodology. 
Speciality care – orthopaedics and 
cardiology.  
knee osteoarthritis), cardiology (coronary heart 
disease). 
Designed for patient to view/read before consultation 
with specialist (some exceptions due to nature of 
condition e.g. abnormal uterine bleeding).  
MacDonald-
Wilson, 
2017, 
USA(56) 
To investigate the implementation of 
decision support practices by Community 
Mental Health Centres and the impact of 
decision support on organisational- and 
individual-level outcomes.  
Quality improvement methodology (mixed-
methods).  
52 Community Mental Health Centres.  
Total number of PtDA topics unclear, but sites asked to 
choose one PtDA to implement from a range of topics 
(e.g. residential rehabilitation, psychiatric 
rehabilitation, outpatient drug and alcohol services 
programme). Limited further information on format / 
intended use but appears to be an online library of 
PtDAs that include decisional balance worksheets. 
Access given by provider.  
Implementation at 52 community mental health centres 
within network of parent organisation, who volunteered to 
take part in initiative. Each site asked to select their own 
intervention and develop own implementation plans using 
PDSA cycles. Learning collaborative approach established. 
Parent organisation supported all aspects of 
implementation (staff training, implementation of 
intervention, information gathering / analysis). Quality 
improvement team established at each site, including one 
member of senior leadership, a quality clinician, direct 
service worker and person in recovery. Trained learning 
collaborative facilitators provided support throughout.  
12 months implementation phase.  
During the 12-month 
implementation period 
52% (27/53) of agencies 
reached the milestone that 
80% of the staff used a 
PtDA with at least one 
patient each month. 
3c, 8 
Scalia, 2017, 
USA(57) 
To use Normalisation Process Theory to 
explore how and why two separate 
healthcare organisations in the USA had 
spontaneously adopted Option GridTM PtDAs 
(for total of eight healthcare issues) in 
routine clinical practice and investigate 
factors that facilitated routine use.  
Case Study (semi-structured interviews) 
Two large sites (one New York, one 
Minneapolis), offering a range of medical 
and dental services, including family 
practice, internal medicine, paediatrics, 
obstetrics and gynaecology, and nurse 
midwifery.  
 
 
 
Option GridTM decision aids (paper-based, one page) 
for patients considering the following issues: 
hypercholestolemia, antibiotics for pharyngitis, 
s iati a, k ee pai , P“A test, Dupu t e s contracture, 
Carpal tunnel syndrome, trigger finger. Designed for 
use in consultation; clinician hands PtDA to patient and 
patient takes home.  
 
 
 
 
Included sites were chosen as they independently 
identified and chose to embed the PtDAs into existing 
workflows and had been and routinely implementing 
Option GridsTM for at least a one-year period beforehand. 
CapitalCare site in New York (primary care organisation 
with 65 physicians across ten sites) utilised total of five 
Option GridTM PtDAs and collected quantitative data via the 
electronic health record. HealthPartners Speciality Center 
in Minnesota (speciality centre providing orthopaedic care 
with over 600 physicians), used three Option Grids 
(Dupu t e s disease, Ca pal Tu el s d o e a d T igge  
Finger); the lead hand surgeon had been an editor for these 
 Option GridsTM that were used during routine 
implementation. Unclear how many of the clinicians at 
each site were involved in routine implementation, but 23 
interviews conducted with nurses, physicians, hospital staff 
and stakeholders across both sites.  
 
Not implementation study per se. But both sites had been 
routinely using relevant Option GridsTM for at least one year 
prior to study.  
No. of sites using Option 
Grid (total number of 
times decision aid given to 
patients. 
 
Capital Care (10 sites):  
High cholesterol – 6 (887) 
Pharyngitis – 2 (163) 
Sciatica – 3 (80) 
Knee pain – 1 (41) 
PSA – 1 (32) 
 
 
HealthPartners: 
Dupu t e s o t a tu e – 
2 (100) 
Carpal tunnel – 2 (200) 
Trigger finger – 2 (200) 
estimated 
3c, 4a, 
4b, 6, 7 
Scalia, 
2018, 
Poland(58) 
 
 
 
To study the use of Option GridTM PtDAs in a 
sample of clinics in Warsaw, Poland, and 
measure their impact on SDM.  
Mixed-methods (pre and post design).   
Three large private healthcare clinics 
Option GridTM decision aids (paper-based, one page) 
for patients who had heartburn, osteoarthritis of the 
knee, or were considering statins. Designed for use in 
consultation. Clinician hands patient PtDA and patient 
takes home. Translated from English to Polish.  
 
Clinicians employed at three large private clinics were 
invited by Medical Director to participate (selected on basis 
of high patient volume). Thirteen clinicians participated 
across three sites (five gastroenterologists, three 
orthopaedic surgeons, three family doctors and two 
cardiologists). Pre-post design; following baseline, all 
Approximately 700 
physicians were involved 
in 2 settings. Total number 
of PtDAs given to patients 
in 2 years = 1700. In one 
setting, 6 out of 10 sites 
6 
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(patients with heartburn, osteoarthritis of 
the knee, or considering statins).  
 
clinicians underwent one-hour training intervention (to 
increase understanding of SDM skills/model, familiarise 
clinicians with Option Grids and CollaboRATE measurement 
instrument, and increase confidence in skills to use Option 
Grid with patients) and were given access to relevant 
Option Grids.  
 
Duration not reported.  
used PtDA; 4 sites did not. 
Physicians reported being 
selective in their use of the 
Option Grid, making 
judgments based on 
patient characteristics. 
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3.1  Programme theories - what works in implementing PtDAs into routine clinical settings?  
A total of 124 e pla ato  If-The  statements were extracted from the included articles. Using the 
CFIR(32) to help understand factors that might influence intervention implementation and effectiveness, 
these statements were refined into eight programme theories (CMO configurations). The programme 
theories are described below, organised under relevant domains of the CFIR,(32) and are summarised in 
Table 2 with suppo ti g data I  is used i  esults to de ote featu es of the i ple e tatio  st ategy, 
e.g. skills training session, automated electronic delivery of PtDA). None of our Theories mapped to 
Domain II of the CFIR. Domains are not mutually exclusive and some CMO configurations could map to 
more than one of the CFIR domains; however, for brevity and clarity, we mapped the eight programme 
theories to the most relevant domain. Due to the limited number of included studies, CMOs have been 
presented generically, with limited contextual reference to specific diseases or decisions; with the 
exception of Theory 2, which is specific to crisis-driven and life-threatening situations.  
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Table 2:  Implementing PtDAs in routine clinical settings programme theories - Context-Mechanism-Outcome configurations identified from 29 articles 
(23 studies)   
Context (C) – Mechanism (M) – Outcome (O) configurations (I = Intervention) Source paper  
I – INTERVENTION CHARACTERISTICS  
Theory 1 – PtDA complexity: simple tools for busy settings  
PtDAs are being implemented in busy healthcare systems with established processes / interventions (clinical and non-clinical) (C). When 
more complex PtDAs are selected (e.g. increased number of additional PtDA related tasks; technical knowledge / support required; 
potential for technical / access issues; increased length of PtDA; unable to easily view PtDA without additional resources e.g. computer 
program etc), HCPs feel that the PtDA competes with existing practice and is more difficult to integrate into their existing system (M), 
making them less likely to use the PtDA (O).  
Bonfils 2018; Brackett 2015; 
Dontje 2013; Lloyd 2013; THF 
2013 
III – INNER SETTING 
Theory 2 - Crisis-driven and life-threatening situations: urgent care needs prioritised over decision support needs 
If the PtDA is implemented in a setting that is crisis-driven or deals with life-threatening issues and diagnoses, which sometimes evoke a 
strong emotional response from the patient (C), HCPs believe that the immediate and urgent needs of the patient are more important (e.g. 
safety / reassurance / emotional support) than decision-making needs (M), and they were less likely to use the PtDA as prescribed (O). 
Bonfils 2018; Hsu 2013; Hsu 
2016; Lloyd 2013; THF 2013 
Theory 3 – Bringing the whole team on board: establishing a common goal, senior-level buy-in, and distributing PtDA tasks appropriately   
3a: Making sure administrative staff also understand PtDA purpose and intended use 
When PtDAs are delivered in settings where the entire healthcare team (including all administrative and clinical staff) have been introduced 
to the PtDA (C), via staff briefing sessions or training (I), administrative staff understood the purpose and intent of the PtDA (M), which 
meant that they were more supportive and motivated to take part in PtDA coordination / distribution tasks (O).  
Berry 2019; Dahl Steffensen 
2018; Lin 2013; Munro 2019; 
Stacey 2018; THF 2013 
 
3b: Distributing PtDA tasks to appropriate team members 
PtDAs are typically implemented in multi-disciplinary teams that include various clinical, support, and administrative staff (C). When 
appropriate PtDA tasks are distributed and delegated to the appropriate individuals across the whole team (I), greater coherence exists 
among the team about the PtDA purpose and intent, individuals are motivated by the distribution of tasks e.g. I  ot i  this  self , 
particularly when senior clinical staff engage, they understand how their task fits with the broader process, and they take ownership over 
their task (M) – making the PtDA more likely to be distributed and used as planned (O).  
 
 
Berry 2019; Feilbelman 2012; 
Munro 2019; Lin 2013; Mangla 
2017; Savelberg 2019; Stacey 
2018; THF 2013 
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Context (C) – Mechanism (M) – Outcome (O) configurations (I = Intervention) Source paper  
3c: Dedicated and ongoing clinical leadership   
HCPs work in ways that align with the expectations and priorities set by the clinical leadership (C). A o siste t li i al leade , ha pio s , 
or leadership team) (I) plays an important role in continued buy-in through ongoing training for new staff, promoting positive attitudes 
towards the approach, presenting feedback on PtDA outcomes, supporting reflection and refinement of PtDA processes, and ensuring the 
approach aligns with key priorities of the healthcare organisation (M). Lack of continued clinical leadership, or staff turnover of the clinical 
champion leading the work, can be detrimental to motivation and the skill set needed to use the PtDA (M) and lead to discontinued use (O). 
Berry 2019; Bonfils 2018; Dahl 
Steffensen 2018; Feibelman 
2017; Giguere 2014; Joseph-
Williams 2017; Lin 2013; Lloyd 
2013; MacDonald-Wilson 2017; 
Scalia 2017; Stacey 2018; THF 
2013 
IV – CHARACTERISTICS OF INDIVIDUALS  
Theory 4. Activating and supporting HCPs to deliver PtDAs: HCPs aware, trained and motivated to change practice   
4a: Raising awareness of PtDA purpose and intended use  
When PtDAs are implemented in teams that do not understand the purpose of the PtDA or its intended use (C), they are less likely to use 
the PtDA as intended (O), because they do not understand the benefits for patients nor the PtDA role in supporting patient decision-making 
(M). Introductory training sessions provided to all team members about the purpose of the PtDA and its benefits (for patients and HCPs (I), 
helps teams decide how to integrate PtDAs into existing work practices (M) which in turn makes it more likely that the PtDA will be adopted 
in routine care (O).   
Berry 2019; Bonfils 2018; Dahl 
Steffensen 2018; Feibelman 
2017; Lin 2013; Lloyd 2013; 
Munro 2019; Savelberg 2019; 
Scalia 2017; THF 2013 
4b: Supporting SDM skills development 
When HCPs lack knowledge of SDM skills (C), they will be less likely to use the PtDA (O) as they do not have confidence in their SDM / PtDA 
delivery skills and / or they do understand how SDM differs from usual practice, and therefore do not understand why the PtDA needs to be 
used (M). SDM skills workshops delivered prior to PtDA implementation (I) provided opportunity for HCPs to practice and develop 
confidence in SDM / PtDA delivery skills, help HCPs to understand how SDM differs from current practice and thus the importance of PtDAs 
(M), which results in increased use and proficiency in using PtDAs with patients (O).  
Brinkman 2017; Feibelman 
2017; Giguere 2014; Joseph-
Williams 2017; Lin 2013; Lloyd 
2013; Mangla 2018; Munro 
2019; Savelberg 2019; Scalia 
2017; Stacey 2015; THF 2013 
Theory 5 – Preparing and encouraging patients to use PtDAs: explicit invitations from clinical team to use PtDA before and during decision-making consultations 
5a: Explicit invitations to use PtDA before decision-making consultations 
Many patients have no experience of receiving or using a PtDA (C). When the clinical team sends explicit invitations (explaining the purpose 
/ process of using PtDA and encouraging patients to engage with PtDA to patients before the decision-making consultation (I), patients 
better understand the relevance and purpose of the PtDA, they perceive that their role in the decision-making process is valid and desired, 
and they are reminded to use the PtDA (M), thus making them more likely to actively engage with the PtDA and use it to help inform their 
decision with a HCP (O).  
 
Berry 2019; Dahl Steffensen 
2018; Dharod 2019; Feibelman 
2017; Joseph-Williams 2017; 
Krist 2017; Munro 2019; THF 
2013 
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Context (C) – Mechanism (M) – Outcome (O) configurations (I = Intervention) Source paper  
5b: Explicit invitations to use PtDA during decision-making consultations 
Significant power-imbalances exist in some consultations, with many patients believing they cannot participate in SDM (C). When HCPs 
provide an explicit invitation during the decision-making consultation to further discuss the PtDA, preferably accompanied by hand-over of 
the PtDA (or duplicate copy, if delivered before consultation) (I) patients will feel that their contribution is valued and sought by the HCP 
and understand the relevance of the PtDA in the decision-making discussion (M), thus making them more likely to share their preferences, 
ask questions and engage in decision-making (thus using the PtDA for its intended purpose) (O).  
Dahl Steffensen 2018; Giguere 
2014; Johnson 2010; Joseph-
Williams 2017; Munro 2019; 
Savelberg 2019 
V - PROCESS 
Theory 6 - Collaborative PtDA development & implementation planning: early and meaningful involvement of clinical teams and providers 
HCPs and providers have pre-existing approaches / processes to communicate options to patients (C). Early involvement of (or ideally, 
initiation by) clinical teams / providers in the development of the PtDA content / implementation planning (I) creates a sense of ownership, 
increases buy-i , helps to legiti ise  o te t, a d e su es the PtDA o te t a d deli e  is o siste t ith u e t p a ti e (M), making it 
more likely to be integrated into routine care (O). 
Dahl Steffensen 2018; Hsu 
2016; Hsu 2013; Johnson 2010; 
Joseph-Williams 2017; Lin 
2013; Lloyd 2013; Munro 2019; 
Savelberg 2019; Scalia 2017; 
Scalia 2018; Sepucha 2017; THF 
2013 
Theory 7 – Earlier distribution of PtDAs: systematising delivery of PtDAs to all eligible patients before decision-making consultations 
In clinical environments with limited staff resources, short appointment times, or short time frames between diagnosis and decision 
discussion (C),  pre-identifying eligible patients and systematising (ideally via IT systems) the timely delivery, completion and return of the 
PtDA to clinicians prior to decision-making consultations (I) de eases li i ia s  o e s a out time to coordinate and do SDM and 
prompts PtDA / SDM use during consultations (M), improving reach and integration of the PtDA (O).  
Belkora 2012; Berry 2019; 
Bonfils 2018; Brackett 2015; 
Dharod 2019; Giguere 2014; 
Krist 2017; Lin 2013; Mangla 
2018; Scalia 2017; Sepucha 
2017; Stacey 2015; Stacey 
2018; THF 2013 
Theory 8 – Li ki g with lear i g healthcare syste s : usi g easure e t to show how PtDA outcomes link with and improve key organisational priorities   
When organisational priorities align with PtDA outcomes a d a lea i g health a e s ste  e.g. ualit  i p o e e t p a ti es / tea s  
exists within an organisation (C), PtDAs should be implemented alongside routinely collected measures that the organisation values (I). 
These measures demonstrate the improvements that result from using PtDAs and also demonstrate to clinical teams that the use of PtDAs 
are valued by the organisation, which makes PtDAs more likely to be integrated into routine care (O).  
Feibelman 2017; Joseph-
Williams 2017; Lloyd 2013; 
MacDonald-Wilson 2017; 
Munro 2019; Savelberg 2019; 
THF 2013  
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I - INTERVENTION CHARACTERITICS  
Theory 1 – PtDA complexity: simple tools for busy settings 
PtDAs are being implemented in busy healthcare systems with established processes / interventions (clinical and 
non-clinical) (C). When more complex PtDAs are selected (I; see Table 2 for examples), HCPs feel that the PtDA 
competes with existing practice and is more difficult to integrate into their existing system (M), making them less 
likely to use the PtDA (O).  
Five articles contribute data to the theory that less complex tools are more likely to be integrated into 
routine care.(35,37,47,50,59) When PtDAs were perceived as more complex by the clinical team, 
especially those PtDAs that required technical knowledge and support, and required an increased 
number of PtDA related tasks and personnel time, the teams felt that they competed with existing 
practice, were too resource intensive, and were more difficult to embed.(35,37,47) Some HCPs reported 
that the shorter and less complex tools (e.g. brief in-consultation paper-based tools) were preferable as 
they fit better with existing practices and required limited additional resources.(35,59,60)  
III – INNER SETTING 
Theory 2 – Crisis-driven and life-threatening situations – urgent care needs prioritised over decision 
support needs  
If the PtDA is implemented in a setting that is crisis-driven or deals with life-threatening issues diagnoses, which 
sometimes evoke a strong emotional response from the patient (C), HCPs believe that the immediate and urgent 
needs of the patient are more important (e.g. safety / reassurance / emotional support) than decision-making 
needs (M), and they were less likely to use the PtDA as prescribed (O). 
Five articles support the theory that PtDAs are less likely to be embedded by HCPs in teams that are 
typically crisis-driven or deal with life-threatening issues.(47,54,55,59,60)  When exploring 
implementation of a PtDA within a community mental health setting Bonfils et al (47) found that staff 
ould ofte  eed to p io itise i ediate patie t eeds o e  PtDA dist i utio  e.g. e e a risis-driven 
li i  a d ou ould use this [ esou e], a d ou ould use that [ esou e], ut the  the e like ell 
the  do t ha e a house,  so so e of that stuff gets in the way.  Life-threatening situations(54) also 
present challenging contexts to embed PtDAs, where HCPs tend to prioritise supporting the immediate 
healthcare needs, and sometimes the more emotional needs, of the patient.  
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Theory 3 – Bringing the whole team on board: establishing a common goal, senior-level buy-in, and 
distributing PtDA tasks appropriately  
3a: Making sure administrative staff also understand PtDA purpose and intended use 
When PtDAs are delivered in settings where the entire healthcare team (including all administrative and clinical 
staff) have been introduced to the PtDA (C), via staff briefing sessions or training (I), administrative staff 
understood the purpose and intent of the PtDA (M), which meant that they were more supportive and motivated to 
take part in PtDA coordination / distribution tasks (O).  
Six articles provide data for this theory.(14,34,40,46,51,59) Various studies reported that PtDA 
integration was more successful when all members of the clinical team had been introduced to the 
PtDA, and not only the HCPs who would be using the tool. When administrative staff understood the 
purpose of the PtDA and how it fits into the patient pathway, they were more supportive of its use and 
motivated to support the distribution processes as part of their administrative role. Joseph-Williams et 
al(13) epo t the sha ed u de sta di g  that e e ged he  all tea  members were involved, and how 
reception staff played a key role in introducing the concept of choice at the very start of the patient 
journey, as well as distributing materials. Other studies also found that administrative staff played a 
critical role in integrating the PtDA into workflows;(40,51) they were responsible for 73% of PtDA 
dist i utio  i  Li  et al s stud . Berry et al(34) fu the  highlight the i po ta e of ohe e e  a out 
purpose and use across the entire team (clinical and administrative); when the administrative staff 
members knew very little about why a PtDA was important or being used, this acted as a barrier to 
implementation. 
3b: Distributing PtDA tasks to appropriate team members   
PtDAs are typically implemented in interprofessional  teams that include various clinical, support, and 
administrative staff (C). When appropriate PtDA tasks are distributed and delegated to the appropriate individuals 
across the whole team (I), greater coherence exists among the team about the PtDA purpose and intent, individuals 
are oti ated y the distri utio  of tasks e.g. I  ot i  this y yself , parti ularly when senior clinical staff 
engage, they understand how their task fits with the broader process, and they take ownership over their task (M) 
– making the PtDA more likely to be distributed and used as planned (O).  
Eight articles support the theory that distributing PtDA tasks among a multi-disciplinary team (clinical 
and non-clinical) is more likely to lead to the PtDA being distributed and used as 
planned.(34,40,41,44,46,51,52,59) Lin et al(40) reported ho  a tea -based practice model,  he e 
clinic staff were empowered to distribute PtDAs, was more successful than a model that relied on 
physicians alone; although they also note that this model can only support, not substitute, HCP 
involvement in patient engagement. Whole team involvement, particularly senior clinical staff, led to 
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pe eptio s su h as I  ot i  this  self  a d this o t e seen as  little  p oje t, (13) which 
motivated individual team members to continue use of PtDAs. Conversely, Fiebleman et al(52) showed 
that when service physicians were not supportive of the PtDA, the remaining staff were less likely to use 
it. Omission of certain team members from the process (e.g. nurses not involved after use of PtDA),(41) 
or inappropriate allocation of PtDA tasks to the wrong team member (e.g. reliance on physicians to 
order PtDAs)(44) can lead to reduced fidelity in the way the PtDA is used, and the subsequent SDM 
discussion, and reduced distribution.  
3c: Dedicated and ongoing clinical leadership 
HCPs work in ways that align with the expectations and priorities set by the clinical leadership (C). A consistent 
li i al leader, ha pio s , or leadership tea  I  plays a  i porta t role i  o ti ued uy-in through ongoing 
training for new staff, promoting positive attitudes towards the approach, presenting feedback on PtDA outcomes, 
supporting reflection and refinement of PtDA processes, and ensuring the approach aligns with key priorities of the 
healthcare organisation (M). Lack of continued clinical leadership, or staff turnover of the clinical champion leading 
the work, can be detrimental to motivation and the skill set needed to use the PtDA (M) and lead to discontinued 
use (O). 
Twelve articles support this theory.(13,14,34,40,46,47,52,53,56,57,59,60) Leadership from senior 
clinicians and managers plays an important role in determining whether teams use and continue to use 
the PtDA. “e e al studies fou d that a li i al lead, o  ha pio  pla ed a sig ifi a t ole i  aki g 
training available, prioritising and keeping SDM and the use of the PtDA high on the agenda, conveying 
seriousness of intent and ensuring evaluation data was being fed back to the team(13,14,46,56)– all 
which results in greater motivation and improved skills set among the team, making it more likely that 
the PtDA use ill e sustai ed. As o e e e  of the O stet i s  tea  i  Joseph-Willia s et al s stud : 
o e you use the big names, the well- espe ted o sulta ts, people sit up a d liste …that s 
eeded. (13) “ alia et al epo t ho  a ha pio  o thopaedi  su geo  influenced colleagues by playing 
a significant role in PtDA development and demonstrating the benefit of using the tool.(58) On the other 
hand, Berry et al(34) found that even when a designated lead was appointed, the absence of a clinical 
lead who is physically present in the clinic and seeing patients acted as a barrier to PtDA use.  
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IV – CHARACTERISTICS OF INDIVIDUALS  
Theory 4 – Activating and supporting HCPs to deliver PtDAs: HCPs aware, trained and motivated to 
change practice  
4a: Awareness of PtDA purpose and intended use 
When PtDAs are implemented in teams that do not understand the purpose of the PtDA or its intended use (C), they 
are less likely to use the PtDA as intended (O), because they do not understand the benefits for patients nor the 
PtDA role in supporting patient decision-making (M). Introductory training sessions provided to all team members 
about the purpose of the PtDA and its benefits (for patients and HCPs(I), helps teams decide how to integrate PtDAs 
into existing work practices (M) which in turn makes it more likely that the PtDA will be adopted in routine care (O).   
Ten articles contributed data to support this theory.(14,34,40,41,47,51,52,57,59,60) Implementation is 
unlikely to occur when teams are not familiar with PtDAs, or lack awareness of the PtDA's purpose and 
intended use, this was an important barrier to routine implementation. For example, one staff member 
i  Bo fils et al s(47) stud  of a e tal health PtDA oted I thi k it s u de utilized e ause people do t 
understand the richness of it…I do t thi k the  ealize ho  u h is o  the e [the PtDA].  When team 
members lack knowledge on why or how the PtDA should be used, they do not understand the benefits 
for patients or the role it plays in the decision-making process, which results in the PtDA being 
underused or misused.(40,41,47) Conversely, when they are clear about the purpose and intended use, 
PtDA adoption is higher.(50–52,59) 
4b: Supporting SDM skills development  
When HCPs lack knowledge of SDM skills (C), they will be less likely to use the PtDA (O) as they do not have 
confidence in their SDM / PtDA delivery skills and / or they do not understand how SDM differs from usual practice, 
and therefore do not understand why the PtDA needs to be used (M). SDM skills workshops delivered prior to PtDA 
implementation (I) provided opportunity for HCPs to practice and develop confidence in SDM / PtDA delivery skills, 
help HCPs to understand how SDM differs from current practice and thus the importance of PtDAs (M), which 
results in increased use and proficiency in using PtDAs with patients (O).  
Twelve articles contributed to this theory.(13,40,41,44,45,48,50–53,57,59) PtDAs are sometimes 
implemented in settings where the HCPs lack knowledge of SDM skills, therefore not understanding how 
SDM differs from their current practice, and thus the additional benefit of using PtDAs (over other 
educational resources). For instance, Joseph-Williams et al(13) found that when asked about SDM 
approaches, many HCPs report e do it al eady.  O  the othe  ha d, if HCPs la k k owledge of SDM 
skills, they often lack confidence in their SDM / PtDA delivery skills, thus holding back from enacting the 
skills. SDM training workshops that incorporate methods for practising skills (e.g. role play scenarios) can 
help HCPs better understand how SDM builds on existing good healthcare communication practices, 
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that SDM is an approach rather than another communication model and enhance SDM skills. Lloyd et al 
reported a significant change in attitudes among HCPs following the workshops; for example, as one 
nurse stated: I itiall  he  e sta ted, like a  of us, I thought e do that a a .  I thi k the 
iggest diffe e e is, ell a tuall , e did t do it ell, (50) These training opportunities encourage 
HCPs to reflect on their current practice and understand and agree the role PtDAs can play in that, 
making it more likely that the PtDA will be used as intended. 
Theory 5 – Preparing and encouraging patients to use PtDAs – explicit invitations from clinical team to 
use PtDA before and during decision-making consultations 
5a: Explicit invitations to use PtDA before decision-making consultations 
Many patients have no experience of receiving or using a PtDA (C). When the clinical team sends explicit invitations 
(explaining the purpose / process of using PtDA and encouraging patients to engage with PtDA) to patients before 
the decision-making consultation (I), patients better understand the relevance and purpose of the PtDA, they 
perceive that their role in the decision-making process is valid and desired, and they are reminded to use the PtDA 
(M), thus making them more likely to actively engage with the PtDA and use it to help inform their decision with a 
HCP (O).  
Eight articles provide support for this theory.(13,14,34,36,39,51,52,59) Many patients are unfamiliar 
with PtDAs and have no experience of using them to support their healthcare decisions. When explicit 
invitations to engage with the PtDA are sent to patients before the decision-making consultation, this 
acts as a prompt for the patient and increases the likelihood that they will use the PtDA.(34) For 
instance, Berry et al(34) found that PtDA use increased from 0-14% in sites that provided written 
material suggesting access, compared to 82-87% in sites where patient care coordinators or physicians 
provided direct email or telephone invitations to engage. Dharod(36) and Krist(39) both found that 
digital delivery of reminders and PtDAs via patient portals was a successful strategy to increase usage. 
Invitatio s that e plai  the pu pose of the PtDA, a d “DM o e oadl , ette  p epa e a d a ti ate  
patients as they help them to understand the relevance of the PtDA and their own role in decision-
making, resulting in increased engagement with the PtDA, and in SDM discussions during 
consultations.(13,14,52)  
5b: Explicit invitations to use PtDA during decision-making consultations  
Significant power-imbalances exist in some consultations, with many patients believing they cannot participate in 
SDM (C). When HCPs provide an explicit invitation during the decision-making consultation to further discuss the 
PtDA, preferably accompanied by hand-over of the PtDA (or duplicate copy, if delivered before consultation) (I) 
patients will feel that their contribution is valued and sought by the HCP and understand the relevance of the PtDA 
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in the decision-making discussion (M), thus making them more likely to share their preferences, ask questions and 
engage in decision-making (thus using the PtDA for its intended purpose) (O).  
Six articles support the theory that explicit invitations from HCPs for the patient to engage with the PtDA 
during decision-making consultations is important to ensuring the PtDA is used in the way intended (e.g. 
helping patients to understand their options and encouraging them to share their  preferences with the 
HCP, ask questions, and engage in the decision-making process).(13,14,41,49,51,53) Patients in Joseph-
Willia s et al s(13) study report that this explicit encouragement from HCPs during consultations 
p o ided pe issio  fo  the  to sha e thei  p efe e es a d e o e i ol ed, a d the hand-over of 
the PtDA during the consultation meant it was used in the way intended; to guide questions for the 
clinician and to prompt them to share their preferences. Conversely, when opportunities to share 
preferences were not provided following receipt of a PtDA, it was not self-evident to patients that they 
could and should express their preferences.(41) 
V - PROCESS 
Theory 6 – Collaborative PtDA development and implementation planning: early and meaningful 
involvement of the clinical team and providers  
HCPs and providers have pre-existing approaches / processes to communicate options to patients (C). Early 
involvement of (or ideally, initiation by) clinical teams / providers in the development of the PtDA content / 
implementation planning (I) creates a sense of ownership, increases buy-i , helps to legiti ise  o te t, e sures 
the PtDA (content and delivery) supports current practice, and ensures that pathway redesign is considered with 
the PtDA in mind (M), making it more likely to be integrated into routine care (O).  
Thirteen articles support this theory, which indicates that early involvement of those affected by change 
or the intended knowledge users was important in integrating a new PtDA into routine 
care.(13,14,41,43,49,51,54,55,57–61) PtDAs were distributed in teams where HCPs had pre-established 
ways of communicating treatment and management options to patients, whether that be via verbal 
communication or existing educational resources, which HCPs often believed to be effective. When the 
team / providers collaboratively contributed to plans regarding PtDA focus, content, design, and 
proposed use from inception, this led to: greater ownership and buy-in to the new approach,(14,50,59) 
sometimes helping HCPs to understand how their existing approaches might not fully support 
SDM;(50,59) greater trust and legitimacy in the content of the tool;(50,59) and development of a tool 
that best fit within their setting, addressing concerns head on.(49,51,55,59,60) The opportunity to adapt 
care pathways meant that the PtDA could fit better with ongoing and simultaneous processes. For 
e a ple, o e east a e  li i  felt that thei  u e t o e-stop-shop  he e y a patient received 
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diagnosis and was asked to make a decision, would not support PtDA use. Instead, they adapted the 
pathway so that the patient could take the PtDA home following diagnosis, and then discuss at a follow-
up appointment.(59) Conversely, lack of involvement of those affected by change resulted in less 
positive attitudes.(54) These mechanisms were important in helping teams to adapt existing practices in 
order to integrate PtDAs into routine care.  
Theory 7 – Earlier distribution of PtDAs: systematising delivery of PtDAs to eligible patients before 
decision-making consultations 
In clinical environments with limited staff resources, short appointment times, or short time frames between 
diagnosis and decision discussion (C),  pre-identifying eligible patients and systematising (ideally via IT systems) the 
timely delivery, completion and return of the PtDA to clinicians prior to decision-making consultations (I) decreases 
clinicians  concerns about time to coordinate and do SDM and prompts PtDA / SDM use during consultations (M), 
improving reach and integration of the PtDA (O).  
Fourteen articles contributed data to this theory.(33–36,39,40,43–47,53,57,59) PtDAs are typically being 
implemented in settings characterised by limited staff resources, multiple competing demands and 
priorities, short appointment times and, sometimes, short time frames within which to deliver the PtDA 
so that it is feasible for the patient to use as intended and relevant. When teams were able to embed 
processes that could pre-identify eligible patients and standardise (ideally automate) the delivery of the 
PtDA prior to the decision-making consultations, this resulted in improved reach of the PtDA, to the 
right patient at the right time.(34,39) Processes that support and standardise the two-way delivery of 
information (i.e. returning patient preferences / questions to the HCP prior to the decision-making 
consultation), acts as a prompt for the HCP to use the PtDA with the patient, meaning HCPs are more 
likely to integrate it into their consultation. Online delivery of PtDAs prior to the consultation also helps 
to overcome time limitations (i.e. if there is limited time available between identifying eligible patients 
and the decision-making consultation taking place).(33,46) HCPs also perceived such processes would 
alleviate concerns regarding the time it would take to deli e  the PtDA e.g. …if you really want to use 
these kinds of Dboxes, and you want to make it work, I think you could organize it so you would have a 
pre-visit .(53) 
Theory 8 – Li ki g with lear i g healthcare syste s : usi g easure e t to show how PtDA 
outcomes link with and improve key organisational priorities   
Whe  orga isatio al priorities alig  ith PtDA out o es a d a lear i g health are syste  e.g. quality 
improvement practices / teams) exists within an organisation (C), PtDAs should be implemented alongside routinely 
collected measures that the organisation values (I). These measures demonstrate the improvements that result 
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from using PtDAs and also demonstrate to clinical teams that the use of PtDAs are valued by the organisation (M), 
which makes PtDAs more likely to be integrated into routine care (O).  
Seven articles contribute data to this theory.(13,41,51,52,56,59,60) Some studies were implementing 
PtDAs in contexts where organisational priorities were aligned with principles of SDM and PtDA 
out o es, a d a lea i g health a e s ste  e isted, he e  s ie e, i fo ati s, i e ti es a d 
culture are aligned for continuous improvement and innovation, with best practices seamlessly 
embedded in the delivery process and new knowledge captured as an integral by-product of the delivery 
e pe ie e. (18) When such a context exists, integration of routinely collected measures alongside the 
PtDA encouraged PtDA use and made it more likely to be sustained in routine care. Clinical team 
members frequently wanted to know whether SDM / PtDA use aligned with existing organisational 
p io ities; as a head a d e k o sulta t o e ted i  Llo d et al s stud (50) if ou ha e t got Boa d 
buy-i , if ou ha e t got suppo t f o  that le el of a age e t, the  e e thi g is a  uphill st uggle . 
By implementing measures alongside PtDAs (tying in with existing routinely collected data or developing 
new measurements), the teams felt that an important part of PtDA use was to drive change and 
improvements, which motivated them to sustain implementation.(13,41,50,56,59) The fact that these 
measures aligned with key organisational priorities showed HCPs that SDM was important, and they 
started to view it as something the organisation does, rather than as another initiative being imposed on 
them and competing with other demands.(13)  
4. Discussion  
4.1 Principal findings  
We developed eight refined theories using data from 23 implementation studies to describe the 
mechanisms by which PtDAs become successfully implemented into routine clinical settings and the 
implementation strategies and contexts that enable these mechanisms. The combined programme 
theory shows that PtDAs are more successfully embedded in healthcare contexts that: make it clear that 
SDM is an organisational priority; take ownership of PtDA implementation by appointing accountable 
leadership; co-produce PtDA implementation strategies with end-users; engage and inform the entire 
team (clinical and administrative) about the PtDAs purpose and intended use; recognise the significance 
every team member plays in PtDA implementation and distributes tasks appropriately; provides 
adequate SDM skills training for those delivering PtDAs; uses simpler tools that integrate into clinic 
workflows; and, prepares and prompts patients to engage in the SDM process so they understand their 
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role in the process and feel comfortable with having open and honest discussions. Using this programme 
theory as a basis, we recommend key strategies that organisations and individuals intending to embed 
PtDAs routinely can use as a practical guide (see Table 3).  
The fifth ke  st ateg , easu i g to i p o e , ill ot e suffi ie t if it fo uses solely on measuring 
uptake of PtDAs by patients, as this may result in tokenistic use of PtDAs, and a focus on distribution 
rather than actual and meaningful engagement with the tool.  Only a few benchmarks for PtDA uptake 
have been reported in the included studies (e.g. % of the staff uses a PtDA ith at least o e i di idual 
ea h o th ) and so we lack insight into reasonable benchmarks for PtDA use. Most studies reported 
actual PtDA distribution (see Table 1); very few focused on how many patients actually used the PtDA. 
An additional challenge of focusing on uptake is that it fails to take into account legitimate reasons for 
the PtDA not being distributed. For example, it might be that the HCP has already informed the patient 
at an earlier consultation, or they have sought an alternative sou e of i fo atio  gi e  the patie t s 
low health literacy. Likewise, patients might also have several good reasons for not using the PtDA that 
has been offered to them.  
Most of the contributing factors we identified relate to the i e  setti g  e.g. ho  the o ga isatio  a d 
the team views SDM and PtDAs, appropriate di isio  of o k, dedi ated leade ship , ha a te isti s of 
i di iduals  e.g. do the tea  ha e the e essa  skills a d self-efficacy to use PtDAs and are patients 
a a e of thei  ole a d feel o fo ta le ei g i ol ed?  a d p o ess  CFIR domains (e.g. collaborative 
development and planning, earlier distribution of PtDA via automated systems).(32) Other than 
complexity of PtDAs (Theory 1), few CMOs mapped to the i te e tio  ha a te isti s  do ai . This 
might indicate that PtDAs as interventions are relatively well-accepted in routine clinical settings, and 
thus challenges with implementation are less likely to do with the tool itself, but more the processes we 
use to embed the tools (e.g. timing of delivery, collaborative agreement on how they are introduced) 
and who they are used by (e.g. do they have the skills to introduce and use the PtDA effectively?). No 
CMOs apped to the oute  setti g  do ai , or the external context within which the organisation 
resides. This most likely reflects the recent emergence of such guidelines and processes and awareness 
of these, rather than them not playing a significant role in successful PtDA implementation. Indeed, 
elsewhere, the emergence of national governance and guidelines has acted as a key driver for SDM 
implementation.(e.g. several NICE guidelines in the UK now recommend SDM supported by PtDAs).(62) 
Ho e e , a othe  o e o st u t of the oute  setti g  do ai , patie t eeds a d esou es , has ot 
been adequately addressed by this review. This signifies that the focus should move from describing 
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eeds assess e ts  du i g the de elop e t of PtDA, a d we should seek to understand patients  
needs and resources in relation to implementation (e.g. delivery modes, readiness for implementation, 
time etc).  
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Table 3: Strategies for routine PtDA implementation – derived from our programme theory of successful PtDA implementation in routine healthcare 
settings  
What does it involve? How does it help? 
Examples of 
studies  
1. Co-production of PtDA content and processes or adapting existing PtDAs to a local level – designing tools and processes that fit everyone 
Early and meaningful involvement of the intended knowledge users in PtDA design and 
implementation planning, via a co-productive approach. It moves beyond seeking the input of 
HCPs / patients on PtDA design / content (without consulting other core team members e.g. 
administrative staff), or views on feasibility of intended PtDA use after several versions of the 
PtDA have already been developed. 
Meaningful involvement from the beginning of the design process: What is the problem our 
patients face in making decisions that are right for them?; How can a PtDA help to address that 
problem (or is there a better way to promote SDM with these patients)?; How can the PtDA be 
used and integrated into the care pathway, and what changes would we need to make?; How can 
appropriate PtDA tasks be delegated to appropriate staff across the entire team? 
Views all end-users as equitable - recognises the skills, abilities, time and other qualities that they 
can bring to the PtDA design and implementation planning process(63) and would involve 
everyone from patients and carers, HCPs, administrative staff, to healthcare managers. 
- increases ownership, trust and buy-in to 
the PtDA 
- leads to equitable division of tasks to 
appropriate team members 
- allows teams to develop a tool that best fit 
within their setting, which addresses the 
needs of all end-users.  
 
Dahl Steffensen 
2018; Hsu 2016; 
Hsu 2013; Johnson 
2010; Joseph-
Williams 2017; Lin 
2013; Lloyd 2013; 
Munro 2019; 
Savelberg 2019; 
Scalia 2017; Scalia 
2018; Sepucha 
2017; THF 2013 
2. Training the entire team – explaining purpose, increasing understanding, developing skills  
Training sessions delivered prior to PtDA implementation are essential.  
SDM / PtDA training has typically focused on upskilling and improving knowledge for HCPs.  
Our findings highlight the importance of training for the entire team.  
Administrative staff are not just passive distributors of the tool; they play critical roles in pre-
identifying eligible patients, successfully integrating PtDAs into workflows, and championing PtDA 
use. Quite often, they will be the first person to introdu e the o ept of hoi e  to patie ts, 
preparing them for PtDA use at the very start of their healthcare journey. However, they can only 
achieve this if training is delivered to the entire team and there is whole-team coherence 
regarding PtDA purpose and intended use. 
- understanding of how PtDA is intended to 
be used and how it fits in the patient 
pathway 
- all staff championing PtDA use 
- improved integration of PtDA into 
workflows 
- coherence on expected PtDA benefits 
- reflection on existing practice and greater 
clarity of how SDM differs and where PtDAs 
fit in that process 
- improved confidence in SDM / PtDA 
delivery 
Berry 2019; Bonfils 
2018; Brinkman 
2017; Dahl 
Steffensen 2018; 
Feibelman 2017; 
Giguere 2014; 
Joseph-Williams 
2017; Lin 2013; 
Lloyd 2013; Mangla 
2018; Munro 2019; 
Savelberg 2019; 
Scalia 2017; Stacey 
2015; THF 2013 
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3.  Preparing and prompting the patient to engage with the PtDA – a key two-step approach 
A two-step process of preparing patients to engage with the PtDA followed by a prompt to engage 
with the PtDA is important in ensuring PtDAs are used in the way intended (i.e. to inform patients 
and support them to share their preferences with the HCP).  
First step (preparing) involves sending an invitation to the patient before the consultation (with an 
accompanying PtDA, if feasible), informing them of the PtDA purpose and encouraging use.  When 
patients are not prepared, they are less likely to understand the purpose of the PtDA and less 
likely to engage with it when presented to them during a consultation. 
Second step (prompting) involves an explicit reminder from the HCP during the consultation to 
engage with the PtDA (ideally accompanied by a duplicate copy if PtDA was distributed 
beforehand).  When patients are not prompted, they are less likely to share their preferences, 
even if they had used the PtDA as intended prior to the consultation.  
Systematising or automating invitation and PtDA delivery can help, but it is not always feasible 
(e.g. general practice) or desirable (e.g. sensitive and significant diagnosis) to pre-identify patients 
ahead of their consultations. However, it is still possible to create a culture of preparedness and 
pe issio  fo  i ol e e t  distilling messages that patient involvement is valued and actively 
sought e.g. through the use of general patient activation campaigns(9,59,64–66) 
Preparing 
- i eases patie ts  u de sta di g of the 
PtDA s purpose, relevance and their own 
role in the decision-making process 
- reinforces that patient input is valued and 
desired 
- reminder for patient to use (if sent before 
consultation) or engage with the PtDA (if 
delivered during consultation). 
 
Prompting 
- pe issio  as pe ei ed  patie ts  fo  
patients to share their preference 
- further validates input in decision-making 
process 
- encourages open and honest discussion of 
patient preferences  
Berry 2019; Dahl 
Steffensen 2018; 
Dharod 2019; 
Feibelman 2017; 
Giguere 2014; 
Johnson 2010; 
Joseph-Williams 
2017; Krist 2017; 
Munro 2019; 
Savelberg 2019; 
THF 2013 
 
 
4.  Senior level buy-in – it’s what we do around here  
Demonstrable leadership from senior clinicians and managers is important for successful PtDA 
implementation, and also sustainability of implementation. Whilst whole team engagement is 
important (see points 1 and 2 above), it is important to identify a core leadership team early on, 
o  at least a li i al ha pio , that ill take o  espo si ilit  fo  d i i g the o k fo a d a d 
maintaining the impetus garnered during the earlier phases of implementation.  
It is not intended as a top-down authoritative strategy, where clinical teams are being told what 
to do by senior team members. It is intended as a facilitative and motivational strategy that 
suppo ts the tea , de o st ati g that the  a e i  it togethe , all o t ibuting to a common 
goal, and have the necessary support to do so. 
- provision of adequate training so team has 
necessary skill set to use PtDAs 
- ensuring PtDAs are prioritised and remain a 
priority in the team 
- ensuring linkage between organisational 
priorities and PtDA outcomes 
- facilitating feedback on PtDA outcomes and 
associated improvements for the team and 
their patients (see also point 5 below). 
- conveys seriousness of intent -creates a 
sense that SDM / PtDAs is hat e do 
a ou d he e  
Berry 2019; Bonfils 
2018; Dahl 
Steffensen 2018; 
Feibelman 2017; 
Giguere 2014; 
Joseph-Williams 
2017; Lin 2013; 
Lloyd 2013; 
MacDonald-Wilson 
2017; Scalia 2017; 
Stacey 2018; THF 
2013 
5. Measuring to improve – linking PtDAs with routinely collected data to demonstrate improvement 
Linking PtDA outcomes with measures that the organisation values is important for successful and 
sustained implementation. When an organisation can see the improvements that result from 
using PtDAs, they are more likely to become integrated into routine clinical care. Ideally, a 
lea i g health a e s ste  ill e i  pla e, hi h ill suppo t this.  
Implementation planners should work to understand the key priorities (at the patient, team, 
organisational, or national guideline / policy level) and link these with key reported PtDA benefits.  
- When PtDA outcomes are linked with 
measures that are valued by the 
organisation, it shows clinical teams that 
PtDAs are an important driver for change 
and improvement, making them more likely 
to be valued and embedded.   
Feibelman 2017; 
Joseph-Williams 
2017; Lloyd 2013; 
MacDonald-Wilson 
2017; Munro 2019; 
Savelberg 2019; 
THF 2013 
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Further, they should identify the data that is already being routinely collected and utilise this were 
possible e.g. Patient Reported Experience Measures (PREMS) or Patient Reported Outcome 
Measures (PROMS). Specifically, designed measures can also be helpful in early stages of 
implementation - see Coulter (2018, page 24-27)(9) for examples of both routine and special 
measures used in various countries.  
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4.2 Comparison with other literature 
This review builds on and aligns with a body of work examining SDM implementation.(6,30,67–70) More 
specifically, several contextual factors identified in this review align with factors described in the 2013 
review.(16) Adequately trained clinicians with the skills and confidence to deliver PtDAs proved to be 
significant facilitators in both reviews (Theory 4), as did processes of systematising earlier delivery of 
PtDAs to patients before healthcare consultations, when feasible (Theory 7).  The previous review also 
reported how distrust in content and lack of clarity of the PtDA purpose in relation to other sources of 
information acted as barriers. This review builds on these ideas by showing how contexts that use a 
collaborative and co-produced approach to PtDA development and implementation can overcome these 
barriers; by increasing a sense of ownership and buy-in, legitimising content, and ensuring the PtDA 
content and delivery can fit with current practice (Theory 6). Competing demands, time pressures and 
poor teamwork also featured as barriers in the 2013 review.(16) We build on these themes by showing 
ho  a hole tea  app oa h , with appropriate distribution of PtDA tasks between clinical and 
administrative staff (Theory 3), can help to overcome dissociation of ownership of PtDA tasks and result 
in more successful integration of the tool. Further, we show how contexts with adequate and ongoing 
leadership for PtDA implementation help to overcome the tendency for busy clinicians to relegate the 
priority of PtDA distribution, by demonstrating how PtDA outcomes align with organisational priorities, 
monitoring progress and improvement, and providing motivation and the skill set needed to use the 
PtDA (Theory 3c).  
Significant contributions of the current review not covered previously include the important role of both 
preparing (either explicitly via earlier distribution of PtDA or implicitly through organisational messaging 
that patient involvement is valued) and prompting patients to engage with PtDAs (Theory 5). This moves 
beyond the preparedness and engagement of clinicians covered previously (16) and focuses more on the 
engagement of the main end-user, the patient. The current review also highlights the importance of 
simpler PtDAs for busy and time limited settings, likely demonstrating further support for brief in-
consultation tools (Theory 1), the challenge of balancing PtDA tasks with o e i ediate patie t s 
needs in crisis-driven and life-threatening situatio s Theo  , a d the i po ta e of lea i g 
health a e s ste  o te ts and linking PtDA outcomes with organisational priorities, thus improving 
integration (Theory 8). 
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Waldron et al have recently published a programme theory of SDM. Whilst the focus of our realist 
review is on the implementation of one specific intervention (i.e. PtDAs) that can support the SDM 
process, there are some consistent observations across the two programme theories. Notably, both 
reviews demonstrate that contexts that provide system level support such as training, senior level 
leadership, organisational support are facilitative (Theories 3c, 4, 8 . We also fou d that self-effi a  
a d e og itio  of the de isio  e e i po ta t e ha is s i  pla  he  o te ts that p o ided 
adequate training (Theory 4) and preparation and patient engagement opportunities (Theory 5) existed. 
The pe eptio  of ti e  e ha is  ide tified  Wald o  et al also featu ed as a prominent 
mechanism in our theories and can somewhat be alleviated by whole team approaches (Theory 3) and 
systematisation of PtDA delivery before clinical consultations (Theory 7).  
4.3 Strengths and limitations  
RRR allowed us to understand the mechanisms by which PtDAs become routinely implemented into 
routine clinical settings and to draw on the expertise of a large international and multi-disciplinary team 
of experts. Inclusivity of this review approach does remain an issue due to the rapid nature,(26) but 
supplementary electronic searches did not identify significant additional papers for consideration and 
the large author group were in agreement that no key studies have been missed.  Given that exclusive 
implementation studies in this field are still relatively sparse, our exclusion of highly controlled trials and 
asso iated si li g studies  ight esult i  data that ould o t i ute to ou  theo ies ei g issed. 
Ho e e , ou  i lusio  of eal- o ld  i ple e tatio  studies should ake these fi di gs o e ele a t 
to policy makers, organisations and HCPs looking to implement PtDA in routine settings. Despite this, we 
acknowledge that these implementation studies typically involved willing volunteers, who were 
selected, for example, for their commitment to embed person-centred-care approaches, or prior success 
in a trial setting. As such, whilst the core strategies identified are likely to be valid in new 
implementation settings, their level of success might vary depending on pre-existing attitudes and 
behaviours. The majority of included studies were also from high income countries with well-established 
and well-resourced healthcare services, and so routine implementation in lower- or middle-income 
countries might look different.  We were limited by the number of overall studies, and the number of 
different contexts that examined PtDA implementation, and this impeded our ability to make more 
specific recommendations of which strategies worked best in which settings (e.g. in line with Theory 3).  
We have limited or no information about what implementation looks like in emergency, paediatric or 
end-of-life settings, for example, or for surrogate decision-making processes. We also have limited 
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understanding of supporting patients with low health literacy and a general lack of inclusivity in PtDA 
approaches. As more implementation studies are conducted, researchers should pay attention to report 
the contexts and mechanism supportive of implementation; it would then be prudent to assess what 
works and does not work in those settings, to broaden our understanding of appropriate strategies that 
can be tailored according to specific contexts.  
4.4 Practice implications    
Globally, health organisations are developing policies that encourage or mandate person-centred 
healthcare approaches when patients are faced with decisions about their health and care. Despite 
these efforts, limited guidance exists regarding the types of strategies that are likely to be the most 
effective in routine healthcare settings. Through this programme theory development, we have been 
able to recommend key strategies to can support successful integration of PtDAs into routine clinical 
settings (Table 3). Building on existing work,(16) this framework emphasises the importance of training 
for entire teams, of better preparing patients to engage with SDM and PtDAs, and of linking PtDA 
outcomes with key organisational priorities and data collection (e.g. PROMS and PREMS). The strategies 
chosen by PtDA implementers should still ultimately depend on context and the key barriers anticipated 
in each setting, for example, the simplicity of PtDA design and delivery method would be more 
significant in settings with very limited time / human resource or limited flexibility in pathway design. 
This review was also not able to explore the added benefit of the more complex and harder to achieve 
strategies (e.g. Strategy 1 - co-production of interventions) over relatively more straightforward 
strategies (e.g. Strategy 2 - skills training for teams); until we have further outcome data reported by 
implementation studies, considerations around feasibility and effort versus expected benefit are still 
needed when choosing strategies. We also fully acknowledge that PtDAs are only one means to improve 
SDM and that true SDM implementation would require a multi-faceted user-centred plan, with 
interventions / approaches targeting attitudes, knowledge, skills and self-efficacy of all end users, whilst 
also addressing key meso and macro level barriers.(13,29). However, the proposed strategies may 
inform an initial framework, and then be supplemented by more specific strategies depending on 
context, and to also address the broader SDM goals.   
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4.5 Conclusions  
The goal for this review was to identify why and how PtDAs become successfully implemented in routine 
healthcare settings. It presents a programme theory derived from implementation studies across a 
range of routine healthcare settings, and recommended strategies that could be used as a practical 
guide by organisations and individuals attempting to embed PtDAs routinely. Further work is needed to 
understand the importance of context in the success of different implementation studies, as these 
studies become available.  
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